EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Sorafenib-Induced Hand-Foot Skin Reaction in a Patient With Acute Myeloid Leukemia Following Haploidentical Stem Cell Transplantation: A Case Report

Christa Davis, Arun Vignesh, Sudha Rangarajan, Murugan Sundaram, Adikrishnan Swaminathan

Cureus · 25.09.2026

DOI: 10.7759/cureus.116921 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 25.09.2026. Verfasst von Christa Davis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Venereology and Leprosy, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sorafenib is an oral multikinase inhibitor approved for advanced hepatocellular carcinoma, renal cell carcinoma, and maintenance therapy in selected patients with FMS-like tyrosine kinase (FLT3)-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. We report the case of a 35-year-old woman with FLT3 internal tandem duplication (FLT3-ITD) and nucleophosmin 1 (NPM1)-positive acute myeloid leukemia (AML) who developed painful hyperkeratotic plantar plaques approximately eight weeks after initiating sorafenib therapy. Clinical examination revealed multiple symmetrical hyperkeratotic plaques involving the pressure-bearing areas of both soles, associated with pain and tenderness, resulting in significant impairment of daily activities. She was diagnosed with sorafenib-induced hand-foot skin reaction (HFSR) and was managed with topical keratolytic and corticosteroid therapy. This case highlights the importance of early recognition and prompt management of sorafenib-induced HFSRs to minimize morbidity and maintain oncological treatment.

Schlagwörter

Stichwörter der Autor:innen

acute myeloid leukemiaadverse drug reactionflt3 mutationhand-foot skin reactionhaploidentical stem cell transplantationmultikinase inhibitorsorafenibtyrosine kinase inhibitor

Autor:innen und Institutionen

  • Dermatology, Venereology and Leprosy, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Zitieren

APA

Davis, C., Vignesh, A., Rangarajan, S., Sundaram, M., & Swaminathan, A. (2026). Sorafenib-Induced Hand-Foot Skin Reaction in a Patient With Acute Myeloid Leukemia Following Haploidentical Stem Cell Transplantation: A Case Report. Cureus. https://doi.org/10.7759/cureus.116921

Vancouver

Davis C, Vignesh A, Rangarajan S, Sundaram M, Swaminathan A. Sorafenib-Induced Hand-Foot Skin Reaction in a Patient With Acute Myeloid Leukemia Following Haploidentical Stem Cell Transplantation: A Case Report. Cureus. 2026. doi:10.7759/cureus.116921

BibTeX
@article{Davis2026,
  author = {Davis, Christa and Vignesh, Arun and Rangarajan, Sudha and Sundaram, Murugan and Swaminathan, Adikrishnan},
  title = {Sorafenib-Induced Hand-Foot Skin Reaction in a Patient With Acute Myeloid Leukemia Following Haploidentical Stem Cell Transplantation: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.116921}
}
Kostenlos starten →